Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05656859
Other study ID # F2022-088
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 6, 2022
Est. completion date December 31, 2023

Study information

Verified date December 2022
Source Aalborg University Hospital
Contact Tobias Christensen, MSc
Phone +4597661359
Email tobc@rn.dk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Department of Health Promotion at Aalborg University Hospital gets patients referred from all the hospital's departments. The Department of Health Promotion offers lifestyle courses to aid preventing disease relapses and further comorbidities to patients referred to other ambulatory treatments at the hospital. For most patients this also includes weight loss, but the primary goal is lifestyle change regarding eating and exercise habits to improve overall health state. Since it is known that eating disorders commonly occurs in individuals seeking help for weight loss, and that the prevalence is larger than in the background population, we also suspect that eating disorders would commonly occur among patients referred to the Department of Health Promotion. Therefore, we aim to investigate the prevalence of eating disorders among patients referred to lifestyle courses at the Department of Health Promotion.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date December 31, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients referred to the Department of Health Promotion at Aalborg University Hospital, Denmark Exclusion Criteria: - Under age 18 - Not able to read and understand Danish - Not able to recieve mail in the danish digital postbox, e-Boks

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Single group
Survey

Locations

Country Name City State
Denmark Aalborg University Hospital Aalborg North Of Jutland

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other The 5-level EQ-5D version (EQ-5D-5L) Self-reported quality of life questionnaire. The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement.
5 minutes
Primary Eating Disorder Examination Questionnaire (EDE-Q) The Eating Disorder Examination Questionnaire (EDE-Q) is a 28-item self-reported questionnaire adapted from the semi-structured interview Eating Disorder Examination (EDE) and designed to assess the range and severity of features associated with a diagnosis of eating disorder using 4 subscales (Restraint, Eating Concern, Shape Concern and Weight Concern) and a global score.
The EDE-Q generates two types of data: frequency data on key behavioural features of eating disorders in terms of number of episodes of the behaviour, and subscale scores reflecting the severity of characteristics of eating disorders.
Higher scores on the global scale and subscales denote more problematic eating behaviours and attitudes.
10 minutes
Secondary Binge Eating Disorder Questionnaire (BED-Q) The Binge Eating Disorder Questionnaire (BED-Q) is a 9-item self-reported questionnaire. Items are rated on a 5-point Likert-type rating scale. Scores range between 0-32 and higher scores denote more problematic binge eating disorder. A diagnostic score that determine patient is diagnosed with Binge Eating Disorder or not can be calculated. 1 item rated "yes" or "no and other items are used to calculated a diagnostic score. 5 minutes
Secondary Grazing Questionnaire (GQ) Grazing Questionnaire (GQ) is a 8-item self-reported questionnaire to measure behaviours and cognitions specific to grazing. Items are rated on a 5-point Likert-type rating scale where higher scores represent more grazing behaviours and cognitions. Scores are summes to form a total score (range: 0-32). 5 minutes
See also
  Status Clinical Trial Phase
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Withdrawn NCT03050632 - Effects of Cognitive and Emotional Functioning on Treatment Outcomes N/A
Completed NCT02567890 - Swedish Body Project for Prevention of Eating Disorders N/A
Completed NCT02484794 - Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application N/A
Completed NCT02252822 - Improving Treatment Engagement for Adolescents With Bulimia Nervosa N/A
Completed NCT02021344 - Mental Health First Aid for College Students N/A
Completed NCT00601354 - Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder N/A
Completed NCT00418977 - Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents N/A
Completed NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Phase 2
Completed NCT00733525 - Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa N/A
Active, not recruiting NCT04779216 - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa Phase 3
Completed NCT04433663 - Eating Disorders, Self Regulation and Mentalization N/A
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Completed NCT04509531 - Building Resilience in Cyberbullying Victims N/A
Recruiting NCT05730348 - Mealtime Anxiety in Eating Disorders
Enrolling by invitation NCT05814653 - A Study to Evaluate Primary Care Treatment for Adolescent Eating Disorders N/A
Completed NCT04506216 - Eating Disorders in Type 1 Insulin-dependent Diabetes Patients N/A